ClinicalTrials.gov
ClinicalTrials.gov Menu

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01678794
Recruitment Status : Active, not recruiting
First Posted : September 5, 2012
Last Update Posted : April 11, 2018
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Horng Chen, Mayo Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 31, 2019
  Estimated Study Completion Date : April 30, 2019